JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, V. G.
Right arrow Articles by Parks, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, V. G.
Right arrow Articles by Parks, D. A.

J Thorac Cardiovasc Surg 1994;107:1222-1227
© 1994 Mosby, Inc.


CARDIOPULMONARY BYPASS,
MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

Xanthine oxidoreductase release after descending thoracic aorta occlusion and reperfusion in rabbits

V. G. Nielsen, MDa, A. Weinbroum, MDa, S. Tan, MDb, P. N. Samuelson, MDa, S. Gelman, MD, PhDc, D. A. Parks, PhDabd


Birmingham, Ala., and Cambridge, Mass.

Partially supported by the National Institutes of Health grant HL 48676.

Received for publication June 17, 1993. Accepted for publication Sept. 14, 1993. Address for reprints: V. G. Nielsen, MD, Department of Anesthesiology, Research Division, University of Alabama at Birmingham, 845 Jefferson Tower, 619 S. 19th St., Birmingham, AL 35233-6810.

Abstract

Cardiopulmonary and other organ dysfunction often occurs after operation on the descending thoracic aorta. Though there are multiple causes of organ dysfunction in this setting, free radical injury may play a prominent role. Xanthine oxidoreductase, an enzyme that generates oxidants after exposure to ischemia, could be released from ischemic liver and intestine during reperfusion. To test this hypothesis, we created aortic occlusion in eight rabbits for 40 minutes by inflation of a 4F Fogarty balloon catheter in the descending thoracic aorta. Eight sham-operated rabbits served as a control group. Two hours of reperfusion followed removal of the balloon catheter. Hemodynamic and acid-base status were maintained near baseline values during reperfusion. Plasma samples were obtained for determination of the activity of the hepatocellular enzymes xanthine oxidoreductase, aspartate aminotransferase, alanine transferase, and lactate dehydrogenase. Plasma xanthine oxidoreductase activity increased significantly (p < 0.001) during reperfusion (729 ± 140µU/ml, mean ± standard error of the mean) compared with baseline (132 ± 18µU/mL). The other enzymes followed a similar pattern of release. We report the release of xanthine oxidoreductase in an animal model that simulates the situation of human thoracic aorta operations. The oxidants produced by the circulating xanthine oxidoreductase observed during reperfusion would likely be toxic to vascular endothelium, potentially contributing to multiple organ dysfunction. (J THORACCARDIOVASCSURG1994;107:1222-7)




This article has been cited by other articles:


Home page
CirculationHome page
J. M. Zimmet and J. M. Hare
Nitroso-Redox Interactions in the Cardiovascular System
Circulation, October 3, 2006; 114(14): 1531 - 1544.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. E. Berry and J. M. Hare
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
J. Physiol., March 15, 2004; 555(3): 589 - 606.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. A. Weinbroum, Y. Kluger, and V. Rudick
Impairment of aortal tone by no flow-reflow conditions and its partial amelioration by mannitol
Ann. Thorac. Surg., May 1, 2000; 69(5): 1439 - 1444.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Houston, A. Estevez, P. Chumley, M. Aslan, S. Marklund, D. A. Parks, and B. A. Freeman
Binding of Xanthine Oxidase to Vascular Endothelium. KINETIC CHARACTERIZATION AND OXIDATIVE IMPAIRMENT OF NITRIC OXIDE-DEPENDENT SIGNALING
J. Biol. Chem., February 19, 1999; 274(8): 4985 - 4994.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Suzuki, F. A. DeLano, D. A. Parks, N. Jamshidi, D. N. Granger, H. Ishii, M. Suematsu, B. W. Zweifach, and G. W. Schmid-Schonbein
Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats
PNAS, April 14, 1998; 95(8): 4754 - 4759.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. G. Nielsen, A. T. McCammon, S. Tan, K. A. Kirk, P. N. Samuelson, and D. A. Parks
Xanthine oxidase inactivation attenuates postocclusion shock after descending thoracic aorta occlusion and reperfusion in rabbits
J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 715 - 722.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The American Association for Thoracic Surgery.